Aussie Study Questions Sanofi's Stilnox, Generics As Safe Insomnia Drug
This article was originally published in PharmAsia News
Executive Summary
An Australian study advised reconsidering the safety of Sanofi's Stilnox (solpidem) and its generic versions for treating insomnia in light of research about its side effects.
An Australian study advised reconsidering the safety of Sanofi's Stilnox (solpidem) and its generic versions for treating insomnia in light of research about its side effects. Researchers at the University of New South Wales said their study found the drug was a contributor or cause of the deaths in more than a third of people taking the drug who died violently or unexpectedly in 2001-2010. Their evidence was so strong, they said, the drug should not be considered a safe drug for sleep problems. (Click here for more
)
"Stilnox Sleeping Drug Considered Unsafe By review" - Sydney Morning Herald (Australia) (7/6/2012)